Literature DB >> 17299718

Immunosuppression during active tuberculosis is characterized by decreased interferon- gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor- beta , and interleukin-4 mRNA levels.

Teri Roberts1, Nulda Beyers, Ana Aguirre, Gerhard Walzl.   

Abstract

The balance between effector and regulatory responses after Mycobacterium tuberculosis infection may dictate outcome and progression to active disease. We investigated effector and regulatory T cell responses in bacille Calmette-Guerin (BCG)-stimulated peripheral blood mononuclear cells and whole blood cultures from persons with active tuberculosis (TB), persons with TB at the end of 6 months of treatment, and healthy control subjects with latent TB infection. All 3 groups displayed BCG-induced increases in effector and regulatory T cell phenotypes as defined by CD4(+)CD25(lo) and CD4(+)CD25(hi) T cells, respectively. In case patients with active disease, BCG stimulation induced the lowest increase of CD25, CD4(+)CD25(hi), CTLA-4, and interferon- gamma . However, these case patients expressed the highest mRNA levels of forkhead box P3, transforming growth factor (TGF)- beta , and interleukin (IL)-4 and a lower T-bet : GATA-3 ratio. There were no significant differences in IL-4 delta 2, IL-10, or TGF- beta receptor-II mRNA expression between groups. Together, these results suggest that immunosuppression seen after mycobacterial stimulation in case patients with active TB is associated with naturally occurring regulatory T cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17299718     DOI: 10.1086/511277

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  49 in total

1.  Suppressed type 1, type 2, and type 17 cytokine responses in active tuberculosis in children.

Authors:  N Pavan Kumar; R Anuradha; R Suresh; R Ganesh; Janani Shankar; V Kumaraswami; Thomas B Nutman; Subash Babu
Journal:  Clin Vaccine Immunol       Date:  2011-09-28

2.  Involvement of regulatory T cells in the immunosuppression characteristic of patients with paracoccidioidomycosis.

Authors:  Maria Carolina Ferreira; Rômulo Tadeu Dias de Oliveira; Rosiane Maria da Silva; Maria Heloisa Souza Lima Blotta; Ronei Luciano Mamoni
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

3.  Depressed Gamma Interferon Responses and Treatment Outcomes in Tuberculosis Patients: a Prospective Cohort Study.

Authors:  Jia-Yih Feng; Sheng-Wei Pan; Shiang-Fen Huang; Ying-Ying Chen; Yung-Yang Lin; Wei-Juin Su
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

4.  Analysis of eight genes modulating interferon gamma and human genetic susceptibility to tuberculosis: a case-control association study.

Authors:  Marlo Möller; Almut Nebel; Paul D van Helden; Stefan Schreiber; Eileen G Hoal
Journal:  BMC Infect Dis       Date:  2010-06-07       Impact factor: 3.090

5.  FOXP3 expression is upregulated in CD4T cells in progressive HIV-1 infection and is a marker of disease severity.

Authors:  Melinda S Suchard; Elizabeth Mayne; Victoria A Green; Sharon Shalekoff; Samantha L Donninger; Wendy S Stevens; Clive M Gray; Caroline T Tiemessen
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

6.  Circulating biomarkers of pulmonary and extrapulmonary tuberculosis in children.

Authors:  Nathella Pavan Kumar; R Anuradha; Bruno B Andrade; N Suresh; R Ganesh; Janani Shankar; V Kumaraswami; Thomas B Nutman; Subash Babu
Journal:  Clin Vaccine Immunol       Date:  2013-03-13

7.  Regulatory T cells modulate Th17 responses in patients with positive tuberculin skin test results.

Authors:  Subash Babu; Sajid Q Bhat; N Pavan Kumar; V Kumaraswami; Thomas B Nutman
Journal:  J Infect Dis       Date:  2010-01-01       Impact factor: 5.226

8.  Differential expression of interleukin-4 (IL-4) and IL-4 delta 2 mRNA, but not transforming growth factor beta (TGF-beta), TGF-beta RII, Foxp3, gamma interferon, T-bet, or GATA-3 mRNA, in patients with fast and slow responses to antituberculosis treatment.

Authors:  Joel Fleury Djoba Siawaya; Nchinya Bennedict Bapela; Katharina Ronacher; Nulda Beyers; Paul van Helden; Gerhard Walzl
Journal:  Clin Vaccine Immunol       Date:  2008-06-25

9.  Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-beta1.

Authors:  Helen A Fletcher; Ansar A Pathan; Tamara K Berthoud; Susanna J Dunachie; Kathryn T Whelan; Nicola C Alder; Clare R Sander; Adrian V S Hill; Helen McShane
Journal:  Vaccine       Date:  2008-08-03       Impact factor: 3.641

10.  Activated mammalian target of rapamycin is associated with T regulatory cell insufficiency in nasal polyps.

Authors:  Geng Xu; Jiahong Xia; Xiaoyang Hua; Han Zhou; Chuanzhao Yu; Zheng Liu; Kemin Cai; Jianbo Shi; Huabin Li
Journal:  Respir Res       Date:  2009-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.